KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $246 | -18.3% | 7,550 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $301 | -5.3% | 7,550 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $318 | -12.2% | 7,550 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $362 | -99.9% | 7,550 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $277,000 | +35.1% | 7,550 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $205,000 | -49.4% | 7,550 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $405,000 | +6.0% | 7,550 | +10.2% | 0.00% | 0.0% |
Q4 2021 | $382,000 | +39.9% | 6,850 | +3.0% | 0.00% | 0.0% |
Q3 2021 | $273,000 | -3.2% | 6,650 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $282,000 | -26.4% | 6,650 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $383,000 | -22.8% | 6,650 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $496,000 | – | 6,650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 321,300 | $12,087,000 | 4.99% |
First Light Asset Management, LLC | 598,213 | $22,505,000 | 2.28% |
Nantahala Capital Management | 845,692 | $31,815,000 | 2.06% |
CHI Advisors LLC | 200,229 | $7,533,000 | 2.03% |
Fairmount Funds Management LLC | 272,498 | $10,251,000 | 1.80% |
Altium Capital Management LP | 88,000 | $3,311,000 | 1.21% |
Orbimed Advisors | 1,679,417 | $63,180,000 | 1.17% |
SPHERA FUNDS MANAGEMENT LTD. | 206,819 | $7,781,000 | 1.08% |
Parkman Healthcare Partners LLC | 99,927 | $3,759,000 | 1.07% |
Soleus Capital Management, L.P. | 146,000 | $5,493,000 | 0.75% |